Pharmaceuticals

Global Parathyroid Hormone Market Forecast 2026–2035: Long-Term Growth Insights

February 18, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the parathyroid hormone market from 2026–2035 with trusted insights from The Business Research Company

What level of growth is expected in the Parathyroid Hormone Market between 2026 and 2030?

The parathyroid hormone market has witnessed rapid expansion in recent years. It is anticipated to grow from $2.51 billion in 2025 to $2.8 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 11.5%. This historical increase can be attributed to several factors including the limited availability of recombinant parathyroid hormone, a low level of disease awareness among patients, reliance on conventional vitamin d therapy, the expanding hospital and clinic infrastructure, and an increasing incidence of post-surgical parathyroid complications.

The parathyroid hormone market size is anticipated to experience substantial expansion in the coming years, with projections indicating a rise to $4.4 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 11.9%. This growth throughout the forecast period is primarily driven by the creation of advanced parathyroid hormone analogues, the increasing adoption of personalized medicine approaches, the expansion of hospital and specialty clinics, the integration of digital patient monitoring tools, and growing government and healthcare initiatives aimed at hypocalcemia and hypoparathyroidism. Key trends identified for the forecast period include the rising incidence of hypocalcemia and hypoparathyroidism, an increasing application of recombinant parathyroid hormone therapies, the evolution of parathyroid hormone analogues for individualized treatment, the broadening of hospital and clinic-based parathyroid care programs, and a strong emphasis on post-surgical management and vitamin d supplementation.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=3427&type=smp

Which Drivers Are Expected To Impact The Parathyroid Hormone Market During The Forecast Period?

The rising number of older adults is anticipated to fuel the expansion of the parathyroid hormone market in the coming years. This demographic, comprising individuals typically aged 65 and older, frequently encounters age-related health issues demanding specialized care and assistance. This societal shift towards a larger elderly demographic is a result of longer life expectancies, improvements in healthcare, and lower birth rates. Parathyroid hormone plays a crucial role for the geriatric population by managing calcium levels and bone metabolism, thereby assisting in the prevention of osteoporosis and fractures, prevalent conditions among older individuals. For example, data from January 2024, provided by the US-based nonprofit Population Reference Bureau, indicates that the American population aged 65 and older is projected to increase from 58 million in 2022 to 82 million by 2050, representing a 47% rise. Furthermore, this specific age group’s proportion of the total population is also forecasted to climb from 17% to 23% within the same timeframe. Consequently, the growing geriatric population is a key driver for the parathyroid hormone market’s growth.

How Is The Parathyroid Hormone Market Divided Into Segments?

The parathyroid hormone market covered in this report is segmented –

1) By Disease Type: Hypocalcemia, Hypoparathyroidism

2) By Product Type: Recombinant Parathyroid Hormone, Parathyroid Hormone Analogues

3) By End-User: Hospitals, Clinics, Other End-Users

Subsegments:

1) By Hypocalcemia: Pseudohypoparathyroidism, Vitamin D Deficiency

2) By Hypoparathyroidism: Post-Surgical Hypoparathyroidism, Idiopathic Hypoparathyroidism

What Trends Are Projected To Support The Growth Of The Parathyroid Hormone Market?

Major companies active in the parathyroid hormone market are concentrating on developing biosimilar versions of parathyroid-based pharmaceuticals, such as prodrugs of parathyroid hormone (PTH), to enhance available treatment options. A prodrug of parathyroid hormone (PTH) functions as an inactive compound that converts into active parathyroid hormone once administered, providing prolonged release and stable therapeutic effects for calcium regulation and bone health. Illustratively, in August 2024, Ascendis Pharma A/S, a Denmark-based biopharmaceutical company, declared that the Food & Drug Administration (FDA) had approved YORVIPATH (palopegteriparatide) as the initial and only therapy for hypoparathyroidism in adults. This once-daily prodrug ensures continuous PTH exposure, benefiting an estimated 70,000 to 90,000 patients in the United States. Ascendis Pharma, the manufacturer, supports patients through its ascendis signature access program (A.S.A.P.) program; however, users must regularly monitor serum calcium levels for potential hypercalcemia or hypocalcemia.

Which Major Industry Participants Are Leading The Parathyroid Hormone Market Growth?

Major companies operating in the parathyroid hormone market are Pfizer Inc., Eli Lilly and Company, Radius Health Inc., Ascendis Pharma, Entera Bio Ltd., Extend Biosciences Inc., Gedeon Richter Plc., Abbott Laboratories, Amgen Inc., Merck & Co. Inc., Novartis AG, F. Hoffmann-La Roche AG, Teva Pharmaceutical Industries Ltd., Alcon Laboratories Inc., Bayer Healthcare, AstraZeneca PLC, Biocon, Dr. Reddy’s Laboratories, Glenmark Pharmaceuticals, Jubilant Life Sciences, Lupin Limited, Sun Pharmaceutical Industries, Torrent Pharmaceuticals, Wockhardt, Cipla Limited

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/parathyroid-hormones-global-market-report

Which Region Is Expected To Experience The Fastest Growth In The Parathyroid Hormone Market?

North America was the largest region in the parathyroid hormone market in 2025. The Middle East is expected to be the fastest-growing region in the global parathyroid hormone market share during the forecast period. The regions covered in the parathyroid hormone market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Parathyroid Hormone Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=3427&type=smp

Browse Through More Reports Similar to the Global Parathyroid Hormone Market 2026, By The Business Research Company

Hormonal Contraceptives Market Report 2026

https://www.thebusinessresearchcompany.com/report/hormonal-contraceptives-global-market-report

Drugs For Hormonal Replacement Therapy Market Report 2026

https://www.thebusinessresearchcompany.com/report/drugs-for-hormonal-replacement-therapy-global-market-report

Thyroid Cancer Drugs Market Report 2026

https://www.thebusinessresearchcompany.com/report/thyroid-cancer-drugs-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795